Unibest
← Back to patent-cliff list

CAS 170502-84-8

(2R,3S)-3-((tert-butoxycarbonyl)amino)-1-hydroxy-4-phenylbutan-2-yl methanesulfonate

Codes: ATAZ-015

Application context (from source-drug indications)

HIV infectionAtazanavir Sulfate/CobicistatHIV infectionAtazanavir SulfateAcquired immunodeficiency syndromeAtazanavir SulfateMycobacterium tuberculosis infectionAtazanavir SulfateType 1 diabetesAtazanavir Sulfate

Source drugs (routes using this intermediate)

DrugTierExpiry
Atazanavir Sulfate/CobicistatTier C — Watch / trade-
Atazanavir SulfateTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.